The p53 saga: the good, the bad, and the dead.
Oren
M
M
Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
D017209:Apoptosis; D035843:Biomedical Research / Q000266:history; D003598:Cytoskeletal Proteins / Q000502:physiology; D016158:Genes, p53; D049673:History, 20th Century; D006801:Humans; D009154:Mutation; D009369:Neoplasms / Q000235:genetics* / Q000473:pathology / Q000503:physiopathology; D017346:Protein Serine-Threonine Kinases; D011518:Proto-Oncogene Proteins / Q000502:physiology; D051057:Proto-Oncogene Proteins c-akt; D015398:Signal Transduction; D015534:Trans-Activators / Q000502:physiology; D016159:Tumor Suppressor Protein p53 / Q000502:physiology; D051176:beta Catenin
C495270:CTNNB1 protein, human; D003598:Cytoskeletal Proteins; D011518:Proto-Oncogene Proteins; D015534:Trans-Activators; D016159:Tumor Suppressor Protein p53; D051176:beta Catenin; D017346:Protein Serine-Threonine Kinases; D051057:Proto-Oncogene Proteins c-akt